Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-07-01
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
KUBO Kohmei
Department of Hematology, Aomori Prefectural Central Hospital
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Komatsu Hirokazu
名古屋市立大学 医学研究科腫瘍･免疫内科学
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Miyawaki S
Division Of Hematology Tokyo Metropolitan Ohtsuka Hospital
-
Miyawaki Shuichi
Division Of Hematology Saiseikai Maebashi Hospital
-
Miyawaki Shuichi
Leukemia Research Center Saiseikai Maebashi Hospital
-
Ohtake S
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
KIYOI Hitoshi
Nagoya University Hospital
-
AMAGASAKI Taro
Novartis Pharma Japan
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Kiyoi Hitoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Sakura Tohru
群馬大学 医学系研究科生体統御内科学
-
Sakura T
Department Of Medicine Saiseikai Maebashi Hospital
-
Kamiya Yoshikazu
愛知がんセンター 血液･細胞療法部
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
TAKESHITA Akihiro
Internal Medicine III, Hamamatsu University School of Medicine
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Sato M
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Kano Hideyuki
Department Of Bioscience School Of Science And Graduate School Of Fundamental Life Science Kitasato
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Adachi Yoko
Department Of Earth And Planetary Sciences Graduate School Of Environmental Studies Nagoya Universit
-
Minami S
Nagasaki Cml Study Group
-
Minami S
(tottori University) United Graduate School Yamaguchi University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Komatsu Hirokazu
Department Of Applied Chemistry Keio University
-
Komatsu Hirokazu
Second Department Of Internal Medicine Nagoya City University School Of Medicine
-
Matsuo Yuji
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University Hospital
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Kiyoi Hitoshi
Department Of Infectious Diseases Nagoya University School Of Medicine
-
Katayama Yoshio
Hematology/oncology Department Of Medicine Kobe University Graduate School Of Medicine
-
Masaki Y
Department Of Hematology And Immunology Kanazawa Medical University
-
KIMURA Yukihiko
Division of Hematology, First Department of Internal Medicine, Tokyo Medical University
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Ueda Ryuzo
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Morita Yasuyoshi
Kinki Univ. School Of Medicine Osaka Jpn
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Ueda Ryuzo
Department Of Applied Physics Waseda University
-
Ohnishi Kazunori
Oncology Center Hamamatsu University School Of Medicine
-
Wakita A
Nagoya City Univ. Graduate School Of Medical Sci. Nagoya Jpn
-
Yasukawa Masaki
Department Of Bioregulatory Medicine Ehime University
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Katayama Yoshio
Second Department Of Internal Medicine Okayama University Medical School
-
Kuroda Hiroyuki
Laboratory Of Chemotherapy Aichi Cancer Center Research Institute
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Sakura Tohru
Division Of Hematology Saiseikai Maebashi Hospital
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Takada Satoru
Leukemia Research Center Saiseikai Maebashi Hospital
-
Yoshida Minoru
Fourth Department Of Internal Medicine Teikyo University School Of Medicine
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Kanazawa University
-
Ohnishi Kazunori
Shikoku National Hospital Matsuyama Jpn
-
Yagasaki Fumiharu
Department Of Public Health Shimane University Faculty Of Medicine
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Yamaguchi Takuhiro
Division Of Biostatistics Tohoku University Graduate School Of Medicine
-
Mikami Yuzuru
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
WAKITA Atsushi
Division of Hematology and Oncology, Nagoya City West Medical Center
-
Adachi Yoko
Department Of Internal Medicine Kobe Central Hospital Of Insurance
-
Koike Koichi
Department Of Hematology Aomori Prefectural Central Hospital
-
Kubo Kohmei
Department Of Hematology Aomori Prefectural Central Hospital
-
Mori Sayaka
Department Of Clinical Laboratory Nagasaki University Hospital
-
Fujita Yasuyuki
Department Of Public Health Shimane University Faculty Of Medicine
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Crescentic Glomerulonephritis with Positive Antineutrophil Cytoplasmic Autoantibody Specific for Myeloperoxidase Associated with Autoimmune Hemolytic Anemia and Thrombocytopenic Purpura
- How High Can We Increase Complete Remission Rate in Adult Acute Myeloid Leukemia?
- 4 Activity of the Science Council of Japan Aiming for Tobacco-free Society in Japan(The 6th Anti-Smoking Promotion Seminar, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Treatment of chronic myeloid leukemia with imatinib mesylate
- Combined primary Aldosteronism and Cushing's Syndrome Due to a single Adrenocortical Adenoma Complicated by Hashimoto's Thyroiditis
- Combined primary Aldosteronism and Cushing's Syndrome Due to a single Adrenocortical Adenoma Complicated by Hashimoto's Thyroiditis
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Detection of Monoclonal Hematopoiesis Using Restriction Fragment Length Polymorphism(RFLP) of Phosphoglycerokinase(PGK) Gene in a Patient with Hypoplastic Myelodysplastic Syndrome(MDS).
- Guest editorial : Introducing progress in hematology in this issue